Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion.
about
The clinical implications of hepatitis B virus genotypes and HBeAg in pediatricsDevelopment of a molecular-beacon assay to detect the G1896A precore mutation in hepatitis B virus-infected individuals.Immune tolerance split between hepatitis B virus precore and core proteins.Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in TaiwanPresence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter.Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in ColombiaHepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric AssayInfluence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion.A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infectionA function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen.Strong association between genotype F and hepatitis B virus (HBV) e antigen-negative variants among HBV-infected argentinean blood donors.Viral hepatitis in the elderly.Management of chronic hepatitis B in children: an unresolved issue.Natural history of chronic hepatitis B virus infection.Hepatitis B and elders: An underestimated issue.Complete genome analysis of hepatitis B virus in human immunodeficiency virus infected and uninfected South Africans.Hepatitis B virus depicts a high degree of conservation during the immune-tolerant phase in familiarly transmitted chronic hepatitis B infection: deep-sequencing and phylogenetic analysis.Molecular characterization of hepatitis B virus X gene in chronic hepatitis B patients.Molecular characterization of hepatitis B virus (HBV) strains circulating in the northern coast of the Persian Gulf and its comparison with worldwide distribution of HBV subgenotype D1.The Possible Role of TLR2 in Chronic Hepatitis B Patients with Precore Mutation.Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.Simultaneous detection of precore/basal core promoter mutations in hepatitis B virus using arrayed primer extension.Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase.Precore stop mutant in anti-HBe-positive phases of chronic hepatitis B virus infection.Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B.Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B.Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analoguesImmunomodulatory Function of HBeAg Related to Short-Sighted Evolution, Transmissibility, and Clinical Manifestation of Hepatitis B Virus
P2860
Q28073299-BAC9F5B4-0D65-4A02-8234-B00B9FF19E94Q33592384-CDCC2C8F-0A12-4DA8-9820-010F8B4751EFQ33835018-81577AD1-09E0-4028-86CC-3425EB884F93Q34231638-B2F82FF5-D66A-4FE7-A9CB-01BC932BD50AQ34252292-0EFCB67F-B7D3-4902-A6E1-0774148160F7Q35011017-E02D22D4-E3C6-42DE-ADC0-500498AA8D98Q35224439-5E3F3B65-B9DA-445A-BF65-B4FF62A07B04Q36037164-5B379C29-C6BD-4602-A0E6-BC47E503AA6FQ36098721-C793DB62-7C4C-4192-8B97-BAD8353F887DQ36738157-68DF662F-7327-45E1-86FF-7D4A49AE3A45Q37051594-4B777D9E-D5A9-46C4-83AF-3B0B9437FC4AQ37571503-DA229AE5-75DC-4DA6-BD88-FBBCDBEDFF3FQ37597481-570D19C3-12FD-46BC-8D1E-EFBA6660A7A8Q37980037-1BBBC6E3-28C2-4D3D-8ADB-63C44DBDFA09Q38215076-DB37B746-C348-4525-8A91-DF62D14D30D7Q38300425-0CDF305F-C892-4AF9-A240-A6A9C1707A71Q38344214-1BD80174-C1D0-4A32-81D7-8F25EC62F3C6Q39987547-277484E0-F60E-4E96-BA22-1979BEE71A32Q41730112-12F779D9-2533-4146-80B9-78E06BD311B3Q41870815-B3BAAB04-DAD9-49D1-9BE1-5882C34F116BQ42236714-2F9B7BAA-5C84-4B40-B54B-5084EF0EE982Q42258017-54D9AB88-FA84-4079-A179-06DD75E69103Q42492943-27416AD1-37C4-4D16-936F-F89774C4E205Q42494618-13DCD528-6B62-44B4-A036-C6A2765E0E41Q45354095-44487EDB-497A-4B9A-8305-361D5A006EA0Q45410934-7B39D7D5-8AB2-4ECA-AF5C-25E614472296Q45731249-AF7B2549-9D03-4393-ACFD-F13247191F12Q47575314-9C467D2A-8291-421E-BD84-6C2378A743BAQ54583576-DBD1FCD6-5882-4C2E-A290-D276431A5C7FQ58376608-6B22A1D5-F880-434B-AB55-CDB0376C3FA3Q58566772-64ADB7F5-9956-463B-B9E5-B7514EB84045
P2860
Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Precore stop mutant in HBeAg-p ...... Ag-to-anti-HBe seroconversion.
@ast
Precore stop mutant in HBeAg-p ...... Ag-to-anti-HBe seroconversion.
@en
type
label
Precore stop mutant in HBeAg-p ...... Ag-to-anti-HBe seroconversion.
@ast
Precore stop mutant in HBeAg-p ...... Ag-to-anti-HBe seroconversion.
@en
prefLabel
Precore stop mutant in HBeAg-p ...... Ag-to-anti-HBe seroconversion.
@ast
Precore stop mutant in HBeAg-p ...... Ag-to-anti-HBe seroconversion.
@en
P2093
P2860
P1476
Precore stop mutant in HBeAg-p ...... Ag-to-anti-HBe seroconversion.
@en
P2093
Chau-Ting Yeh
Chia-Ming Chu
Ching-Song Lee
I-Shyan Sheen
P2860
P356
10.1128/JCM.40.1.16-21.2002
P407
P50
P577
2002-01-01T00:00:00Z